Buscar

01/10/2022 Effects of treatment with a carbon monoxide donor and an activator of heme oxygenase 1 on the nociceptive, apoptotic and/or oxidative alterations induced by persistent inflammatory pain in the central nervous system of mice
Cazuza, RA, Batalle, G, Bai, X, Leite-Panissi, CRA, Pol, O. Effects of treatment with a carbon monoxide donor and an activator of heme oxygenase 1 on the nociceptive, apoptotic and/or oxidative alterations induced by persistent inflammatory pain in the central nervous system of mice. BRAIN RESEARCH BULLETIN. 2022; 188DOI:10.1016/j.brainresbull.2022.08.004. PMID:35952846. IF:3.800(Q2/5D).
01/09/2022 Hydrogen-Rich Water as a Novel Therapeutic Strategy for the Affective Disorders Linked with Chronic Neuropathic Pain in Mice
Martinez-Serrat, M, Martinez-Martel, I, Coral-Perez, S, Bai, X, Batalle, G, Pol, O. Hydrogen-Rich Water as a Novel Therapeutic Strategy for the Affective Disorders Linked with Chronic Neuropathic Pain in Mice. Antioxidants. 2022; 11(9)DOI:10.3390/antiox11091826. PMID:36139900. IF:7.000(Q1/1D).
01/07/2022 Hydrogen Sulfide Increases the Analgesic Effects of mu- and delta-Opioid Receptors during Neuropathic Pain: Pathways Implicated
Bai, X, Batalle, G, Balboni, G, Pol, O. Hydrogen Sulfide Increases the Analgesic Effects of mu- and delta-Opioid Receptors during Neuropathic Pain: Pathways Implicated. Antioxidants. 2022; 11(7)DOI:10.3390/antiox11071321. PMID:. IF:7.000(Q1/1D).
01/07/2022 The Interaction between Carbon Monoxide and Hydrogen Sulfide during Chronic Joint Pain in Young Female Mice
Batallé G., Bai X., Pol O.. The Interaction between Carbon Monoxide and Hydrogen Sulfide during Chronic Joint Pain in Young Female Mice. Antioxidants. 2022; 11(7)DOI:10.3390/antiox11071271. PMID:35883761. IF:7.000(Q1/1D).
01/05/2022 Effects of heme oxygenase 1 in the molecular changes and neuropathy associated with type 2 diabetes in mice
Pouso-Vázquez E., Bai X., Batallé G., Roch G., Pol O.. Effects of heme oxygenase 1 in the molecular changes and neuropathy associated with type 2 diabetes in mice. BIOCHEMICAL PHARMACOLOGY. 2022; 199DOI:10.1016/j.bcp.2022.114987. PMID:35276215. IF:5.800(Q1/2D).
01/01/2022 The Beneficial Effects of Heme Oxygenase 1 and Hydrogen Sulfide Activation in the Management of Neuropathic Pain, Anxiety- and Depressive-like Effects of Paclitaxel in Mice
Roch, G, Batalle, G, Bai, X, Pouso-Vazquez, E, Rodriguez, L, Pol, O. The Beneficial Effects of Heme Oxygenase 1 and Hydrogen Sulfide Activation in the Management of Neuropathic Pain, Anxiety- and Depressive-like Effects of Paclitaxel in Mice. Antioxidants. 2022; 11(1)DOI:10.3390/antiox11010122. PMID:35052626. IF:7.000(Q1/1D).
01/01/2022 CO and pain management
Pol O.. CO and pain management. Carbon Monoxide In Drug Discovery: Basics, Pharmacology, And Therapeutic Potential. 2022; DOI:10.1002/9781119783435.ch29. PMID:. IF:(Q/D).
01/12/2021 Hydrogen Sulfide Inhibits Inflammatory Pain and Enhances the Analgesic Properties of Delta Opioid Receptors
Porta, A, Rodriguez, L, Bai, X, Batalle, G, Roch, G, Pouso-Vazquez, E, Balboni, G, Pol, O. Hydrogen Sulfide Inhibits Inflammatory Pain and Enhances the Analgesic Properties of Delta Opioid Receptors. Antioxidants. 2021; 10(12)DOI:10.3390/antiox10121977. PMID:34943080. IF:7.675(Q1/1D).
01/10/2021 The Recovery of Cognitive and Affective Deficiencies Linked with Chronic Osteoarthritis Pain and Implicated Pathways by Slow-Releasing Hydrogen Sulfide Treatment
Batalle, G, Bai, X, Pouso-Vazquez, E, Roch, G, Rodriguez, L, Pol, O. The Recovery of Cognitive and Affective Deficiencies Linked with Chronic Osteoarthritis Pain and Implicated Pathways by Slow-Releasing Hydrogen Sulfide Treatment. Antioxidants. 2021; 10(10)DOI:10.3390/antiox10101632. PMID:34679766. IF:7.675(Q1/1D).
01/07/2021 Treatment with 5-fluoro-2-oxindole Increases the Antinociceptive Effects of Morphine and Inhibits Neuropathic Pain
Ferreira-Chamorro, P, Redondo, A, Riego, G, Pol, O. Treatment with 5-fluoro-2-oxindole Increases the Antinociceptive Effects of Morphine and Inhibits Neuropathic Pain. CELLULAR AND MOLECULAR NEUROBIOLOGY. 2021; 41(5)DOI:10.1007/s10571-020-00952-w. PMID:32880099. IF:4.231(Q2/5D).
01/07/2021 The Anxiolytic and Antidepressant Effects of Diallyl Disulfide and GYY4137 in Animals with Chronic Neuropathic Pain
Bai, X, Batalle, G, Pol, O. The Anxiolytic and Antidepressant Effects of Diallyl Disulfide and GYY4137 in Animals with Chronic Neuropathic Pain. Antioxidants. 2021; 10(7)DOI:10.3390/antiox10071074. PMID:34356307. IF:7.675(Q1/1D).
01/01/2022 Impact of pre-admission antithrombotic therapy on disease severity and mortality in patients hospitalized for COVID-19
Corrochano, M, Acosta-Isaac, R, Mojal, S, Miqueleiz, S, Rodriguez, D, Quijada-Manuitt, MA, Fraga, E, Castillo-Ocana, M, Amaro-Hosey, K, Albiol, N, Soria, JM, Antonijoan, RM, Souto, JC. Impact of pre-admission antithrombotic therapy on disease severity and mortality in patients hospitalized for COVID-19. JOURNAL OF THROMBOSIS AND THROMBOLYSIS. 2022; 53(1)DOI:10.1007/s11239-021-02507-2. PMID:34138399. IF:4.000(Q2/4D).
01/10/2021 Dopamine modulations of reward-driven music memory consolidation
Ferreri, L, Mas-Herrero, E, Cardona, G, Zatorre, RJ, Antonijoan, RM, Valle, M, Riba, J, Ripolles, P, Rodriguez-Fornells, A. Dopamine modulations of reward-driven music memory consolidation. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. 2021; 1502(1)DOI:10.1111/nyas.14656. PMID:34247392. IF:6.499(Q1/2D).
01/12/2025 Melatonin as a Possible Stimulus to Unmask an Oxytocin-Deficient State in Hypopituitarism and Hypothalamic Damage
Asla, Q, Garrido, M, Urgell, E, Terzan, S, Santos, A, Varghese, N, Atila, C, Biagetti, B, Plessow, F, Christ-Crain, M, Eckert, A, Webb, SM, Lawson, EA, Aulinas, A. Melatonin as a Possible Stimulus to Unmask an Oxytocin-Deficient State in Hypopituitarism and Hypothalamic Damage. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2025; 110(12)DOI:10.1210/clinem/dgaf201. PMID:40166823. IF:5.100(Q1/2D).
01/09/2025 Introduction of Biopharmaceuticals in Europe: A Cross-Sectional Study of Early Diffusion Patterns and Data Availability
Veszelei, I, Godman, B, Aaltonen, K, Selke, GW, Garuoliene, K, Cangini, A, Kurdi, A, Rodrigues, AT, Pontes, C, Torre, C, Lunghi, C, Burton, E, Poplavska, E, Jónsdóttir, F, Petrova, G, Langner, I, Iaru, I, Odnoletkova, I, Slaby, J, Gvozdanovic, K, Saastamoinen, L, Laius, O, Benkö, R, Ziogaite, S, McTaggart, S, Mueller, T, de Pando, T, Tesar, T, Mitkova, Z, Wettermark, B. Introduction of Biopharmaceuticals in Europe: A Cross-Sectional Study of Early Diffusion Patterns and Data Availability. BIODRUGS. 2025; 39(5)DOI:10.1007/s40259-025-00732-2. PMID:40779010. IF:6.900(Q1/1D).
12/08/2025 Update on the Prevalence, Incidence, Mortality, and Trends in Treatment of Inflammatory Bowel Disease in a Population-Based Registry in Catalonia Between 2017 and 2023
Brunet-Mas, E, Garcia-Sagué, B, Vela, E, Pontes, C, Melcarne, L, Frisancho, LE, Llovet, LP, Pedregal-Pascual, P, Lario, S, Ramírez-Lázaro, MJ, Villoria, A, Calvet, X. Update on the Prevalence, Incidence, Mortality, and Trends in Treatment of Inflammatory Bowel Disease in a Population-Based Registry in Catalonia Between 2017 and 2023. Journal of Clinical Medicine. 2025; 14(16)DOI:10.3390/jcm14165711. PMID:40869536. IF:2.900(Q1/2D).
01/04/2025 Safety, Tolerability and Pharmacokinetics of Sodium Tungstate (OXO-001) in Healthy Female Volunteers of Childbearing Age: A Randomized, Double-Blind, Dose-Finding, and Placebo-Controlled Phase I Study
Arbat, A, Canals, I, Coimbra, J, Molina-Perelló, P, Llorens, M, Torres, R, Perello, J, Moral-Blanch, M, Antonijoan, RM, Calaf, J. Safety, Tolerability and Pharmacokinetics of Sodium Tungstate (OXO-001) in Healthy Female Volunteers of Childbearing Age: A Randomized, Double-Blind, Dose-Finding, and Placebo-Controlled Phase I Study. International Journal of Fertility & Sterility. 2025; 19(2)DOI:10.22074/ijfs.2024.2013704.1554. PMID:40200776. IF:0.471(Q4/10D).
25/03/2025 Use of Bayesian approaches in oncology clinical trials: A cross-sectional analysis
Lopez-Rey, BG, Carot-Sans, G, Ouchi, D, Torres, F, Pontes, C. Use of Bayesian approaches in oncology clinical trials: A cross-sectional analysis. Frontiers in Pharmacology. 2025; 16DOI:10.3389/fphar.2025.1548997. PMID:40201693. IF:4.800(Q1/2D).
13/12/2024 A cross-sectional study of Phase I Clinical Trials authorized in Spain: An analysis of characteristics and times of execution based on experience
Filippi-Arriaga, F, Molina, P, Delgado-Espinoza, CE, Antonijoan, R. A cross-sectional study of Phase I Clinical Trials authorized in Spain: An analysis of characteristics and times of execution based on experience. MEDICINA CLINICA. 2024; 163(11)DOI:10.1016/j.medcli.2024.06.001. PMID:39043476. IF:2.100(Q2/3D).
18/11/2024 A 25-Year Retrospective of Health IT Infrastructure Building: The Example of the Catalonia Region
Piera-Jiménez, J, Carot-Sans, G, Ramiro-Pareta, M, Nogueras, MM, Folguera-Ródenas, J, Ródenas, P, Jiménez-Rueda, A, Navarro, TD, Palacios, JAM, Fajardo, JC, Campillo, JU, Vela, E, Monterde, D, Valero-Bover, D, Bonet, T, Tarrasó-Urios, G, Cantenys-Saba, R, Fabregat-Fabregat, P, Oliveros, BG, Berdún, J, Michelena, X, Cano, I, González-Colom, R, Roca, J, Solans, O, Pontes, C, Pérez-Sust, P. A 25-Year Retrospective of Health IT Infrastructure Building: The Example of the Catalonia Region. JOURNAL OF MEDICAL INTERNET RESEARCH. 2024; 26DOI:10.2196/58933. PMID:39556831. IF:6.000(Q1/1D).